# A Research Study Looking Into Blood Levels of NNC0174-0833 in People With Normal and Impaired Kidney Function

> **NCT04209049** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 33 (actual)

## Conditions studied

- Overweight
- Obesity

## Interventions

- **DRUG:** NNC0174-0833

## Key facts

- **NCT ID:** NCT04209049
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-15
- **Primary completion:** 2021-01-05
- **Final completion:** 2021-01-05
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2021-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04209049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04209049, "A Research Study Looking Into Blood Levels of NNC0174-0833 in People With Normal and Impaired Kidney Function". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04209049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*